Dr. Lucy Abgaryan, the co-founder and CEO of GrittGene Therapeutics, a biotech company based in Los Angeles, California, joins us to discuss how her company is working to find treatments for Myotonic Dystrophy, a rare genetic disorder that causes progressive muscle loss and weakness. Lucy also shared with us her experience in trying to find opportunities to work with the local Armenian biotech industry.
EVN Report’s mission is to empower Armenia, inspire the diaspora and inform the world through sound, credible and fact-based reporting and commentary. Our goal is to increase public trust in the media. EVN Report is the media arm of EVN News Foundation registered in the Republic of Armenia in 2017.
SUPPORT INDEPENDANT JOURNALISM